PubMed:18805725
Annnotations
PubTator4TogoVar
Id | Subject | Object | Predicate | Lexical cue | proteinmutation |
---|---|---|---|---|---|
18805725_0 | 96-102 | ProteinMutation | denotes | G2019S | rs34637584 |
18805725_1 | 107-113 | ProteinMutation | denotes | R1441C | rs33939927 |
18805725_2 | 458-464 | ProteinMutation | denotes | G2019S | rs34637584 |
18805725_3 | 725-731 | ProteinMutation | denotes | G2019S | rs34637584 |
18805725_4 | 751-757 | ProteinMutation | denotes | R1441C | rs33939927 |
18805725_5 | 793-799 | ProteinMutation | denotes | G2019S | rs34637584 |
18805725_6 | 1039-1045 | ProteinMutation | denotes | G2019S | rs34637584 |
18805725_7 | 1050-1056 | ProteinMutation | denotes | R1441C | rs33939927 |
18805725_8 | 1200-1206 | ProteinMutation | denotes | G2019S | rs34637584 |
c_corpus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 26-31 | PR:Q5S006 | denotes | LRRK2 |
T2 | 26-31 | PR:000003033 | denotes | LRRK2 |
T3 | 26-31 | PR:Q5S007 | denotes | LRRK2 |
T8 | 136-155 | D010300 | denotes | Parkinson's disease |
T9 | 136-155 | D010300 | denotes | Parkinson's disease |
T12 | 183-188 | PR:Q5S006 | denotes | LRRK2 |
T13 | 183-188 | PR:000003033 | denotes | LRRK2 |
T14 | 183-188 | PR:Q5S007 | denotes | LRRK2 |
T15 | 189-193 | SO:0000704 | denotes | gene |
T20 | 251-270 | D010300 | denotes | Parkinson's disease |
T21 | 251-270 | D010300 | denotes | Parkinson's disease |
T24 | 452-457 | PR:Q5S006 | denotes | LRRK2 |
T25 | 452-457 | PR:000003033 | denotes | LRRK2 |
T26 | 452-457 | PR:Q5S007 | denotes | LRRK2 |
T27 | 690-695 | PR:Q5S006 | denotes | LRRK2 |
T28 | 690-695 | PR:000003033 | denotes | LRRK2 |
T29 | 690-695 | PR:Q5S007 | denotes | LRRK2 |
T30 | 696-700 | SO:0000704 | denotes | gene |
T31 | 765-773 | SO:0000109 | denotes | mutation |
T32 | 800-808 | CHEBI:78059 | denotes | carriers |
T33 | 1033-1038 | PR:Q5S006 | denotes | LRRK2 |
T34 | 1033-1038 | PR:000003033 | denotes | LRRK2 |
T35 | 1033-1038 | PR:Q5S007 | denotes | LRRK2 |
T36 | 1107-1115 | SO:0000109 | denotes | mutation |
T37 | 1207-1214 | SO:0001147 | denotes | variant |
T38 | 1218-1221 | PR:Q0VIA1 | denotes | ten |
T39 | 1291-1299 | SO:0000109 | denotes | mutation |
UseCases_ArguminSci_Discourse
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-165 | DRI_Background | denotes | Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients. |
T2 | 166-276 | DRI_Background | denotes | Mutations in the LRRK2 gene are the most common known cause of familial and sporadic Parkinson's disease (PD). |
T3 | 277-397 | DRI_Background | denotes | Few studies performed to date to assess frequency of these mutations are actually only representative of specific areas. |
T4 | 398-451 | DRI_Approach | denotes | Here we study the frequency and clinical phenotype of |
T5 | 452-464 | Token_Label.OUTSIDE | denotes | LRRK2 G2019S |
T6 | 464-560 | DRI_Approach | denotes | , I2020T and R1441C/G/H mutations in 356 Sardinian patients with idiopathic PD and 208 controls. |
T7 | 561-640 | DRI_Background | denotes | Seventeen additional subjects, relatives of PD mutated probands, were enrolled. |
T8 | 641-774 | DRI_Background | denotes | Eight patients were mutated in heterozygosis for LRRK2 gene (2.3%): six carried the G2019S (1.7%) and two the R1441C (0.6%) mutation. |
T9 | 775-979 | DRI_Approach | denotes | Three PD patients G2019S carriers (50%) were detected in two contiguous villages comprising 3921 inhabitants while the other three (50%) were identified in the remaining population of 796,079 inhabitants. |
T10 | 980-1032 | DRI_Approach | denotes | Only one mutated proband had a family history of PD. |
T11 | 1033-1038 | REPLACED | denotes | LRRK2 |
T12 | 1039-1045 | Token_Label.OUTSIDE | denotes | G2019S |
T13 | 1046-1178 | DRI_Background | denotes | and R1441C mutations associated with PD were not an uncommon mutation in a Sardinian population, especially in sporadic PD patients. |
T14 | 1179-1365 | DRI_Background | denotes | The detection of the G2019S variant in ten unaffected relatives confirms a reduced penetrance of the underlying mutation and might explain its prevalence among patients with sporadic PD. |
T15 | 1366-1542 | DRI_Background | denotes | These findings may provide new insights into the importance of studies of frequency of LRKK2 mutations in PD patients originating from small ethnically homogeneous populations. |
PubMed_ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 166-276 | DRI_Background | denotes | Mutations in the LRRK2 gene are the most common known cause of familial and sporadic Parkinson's disease (PD). |
T2 | 277-397 | DRI_Background | denotes | Few studies performed to date to assess frequency of these mutations are actually only representative of specific areas. |
T3 | 398-451 | DRI_Approach | denotes | Here we study the frequency and clinical phenotype of |
T4 | 464-560 | DRI_Approach | denotes | , I2020T and R1441C/G/H mutations in 356 Sardinian patients with idiopathic PD and 208 controls. |
T5 | 561-640 | DRI_Background | denotes | Seventeen additional subjects, relatives of PD mutated probands, were enrolled. |
T6 | 641-774 | DRI_Background | denotes | Eight patients were mutated in heterozygosis for LRRK2 gene (2.3%): six carried the G2019S (1.7%) and two the R1441C (0.6%) mutation. |
T7 | 775-979 | DRI_Approach | denotes | Three PD patients G2019S carriers (50%) were detected in two contiguous villages comprising 3921 inhabitants while the other three (50%) were identified in the remaining population of 796,079 inhabitants. |
T8 | 980-1032 | DRI_Approach | denotes | Only one mutated proband had a family history of PD. |
T9 | 1033-1038 | REPLACED | denotes | LRRK2 |
T10 | 1046-1178 | DRI_Background | denotes | and R1441C mutations associated with PD were not an uncommon mutation in a Sardinian population, especially in sporadic PD patients. |
T11 | 1179-1365 | DRI_Background | denotes | The detection of the G2019S variant in ten unaffected relatives confirms a reduced penetrance of the underlying mutation and might explain its prevalence among patients with sporadic PD. |
T12 | 1366-1542 | DRI_Background | denotes | These findings may provide new insights into the importance of studies of frequency of LRKK2 mutations in PD patients originating from small ethnically homogeneous populations. |
DisGeNET5_variant_disease
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
18805725-8#17#23#geners33939927 | 1050-1056 | geners33939927 | denotes | R1441C |
18805725-8#50#52#diseaseC0030567 | 1083-1085 | diseaseC0030567 | denotes | PD |
18805725-9#21#27#geners34637584 | 1200-1206 | geners34637584 | denotes | G2019S |
18805725-9#183#185#diseaseC0030567 | 1362-1364 | diseaseC0030567 | denotes | PD |
17#23#geners3393992750#52#diseaseC0030567 | 18805725-8#17#23#geners33939927 | 18805725-8#50#52#diseaseC0030567 | associated_with | R1441C,PD |
21#27#geners34637584183#185#diseaseC0030567 | 18805725-9#21#27#geners34637584 | 18805725-9#183#185#diseaseC0030567 | associated_with | G2019S,PD |
DisGeNET5_gene_disease
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
18805725-8#0#5#gene120892 | 1033-1038 | gene120892 | denotes | LRRK2 |
18805725-8#50#52#diseaseC0030567 | 1083-1085 | diseaseC0030567 | denotes | PD |
0#5#gene12089250#52#diseaseC0030567 | 18805725-8#0#5#gene120892 | 18805725-8#50#52#diseaseC0030567 | associated_with | LRRK2,PD |